Advanced search
Publication Cover
mAbs Volume 6, 2014 - Issue 6
Submit an article Journal homepage
1,234
Views
28
CrossRef citations to date
0
Altmetric
REPORTS

VEGF neutralizing aerosol therapy in primary pulmonary adenocarcinoma with K-ras activating-mutations

Virginie HervéUniversité François Rabelais, UMR, Tours, France;INSERM, UMR, Tours, France;Centre d’Etude des Pathologies Respiratoires, UMR, Tours, France
,
Nathalie RabbeSorbonne Universités, UPMC Univ Paris, Theranoscan, Paris, France;AP-HP, Hôpital Tenon, Service de Pneumologie, F-75970, Paris, France
,
Laurent GuilleminaultCentre d’Etude des Pathologies Respiratoires, UMR, Tours, France;Université François Rabelais, EA, Tours, France;Service de Pneumologie et Explorations Fonctionnelles Respiratoires, Hôpital Bretonneau, Tours, France
,
Flora PaulCentre d’Etude des Pathologies Respiratoires, UMR, Tours, France;Université François Rabelais, EA, Tours, France
,
Laurène SchlickSorbonne Universités, UPMC Univ Paris, Theranoscan, Paris, France;AP-HP, Hôpital Tenon, Service de Pneumologie, F-75970, Paris, France
,
Nicolas AzzopardiUniversité François-Rabelais de Tours, CNRS, GICC UMR, Tours, France
,
Michael DuruisseauxSorbonne Universités, UPMC Univ Paris, Theranoscan, Paris, France
,
Delphine FouquenetUniversité François Rabelais, UMR, Tours, France;INSERM, UMR, Tours, France;Centre d’Etude des Pathologies Respiratoires, UMR, Tours, France
,
Jérôme MontharuUniversité François Rabelais, PST Animaleries, Tours, France
,
Françoise RediniINSERM, UMR957, Nantes, France
,
Gilles PaintaudUniversité François-Rabelais de Tours, CNRS, GICC UMR, CHRU de Tours, Laboratoire de pharmacologie-Toxicologie, Tours, France
,
Etienne LemariéCentre d’Etude des Pathologies Respiratoires, UMR, Tours, France;Université François Rabelais, EA, Tours, France
,
Jacques CadranelSorbonne Universités, UPMC Univ Paris, Theranoscan, Paris, France;AP-HP, Hôpital Tenon, Service de Pneumologie, F-75970, Paris, France
,
Marie WislezSorbonne Universités, UPMC Univ Paris, Theranoscan, Paris, France;AP-HP, Hôpital Tenon, Service de Pneumologie, F-75970, Paris, France
&
Nathalie Heuzé-Vourc’hCentre d’Etude des Pathologies Respiratoires, UMR, Tours, France;Université François Rabelais, EA, Tours, FranceCorrespondence[email protected]
 show all
Pages 1638-1648 | Received 20 May 2014, Accepted 12 Aug 2014, Published online: 15 Dec 2014

Citations (28)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (7)

Thomas Sécher & Nathalie Heuzé-Vourc’h. (2023) Barriers for orally inhaled therapeutic antibodies. Expert Opinion on Drug Delivery 20:8, pages 1071-1084.
Read now
Tanvirul Hye, Sakib M. Moinuddin, Tanoy Sarkar, Trieu Nguyen, Dipongkor Saha & Fakhrul Ahsan. (2023) An evolving perspective on novel modified release drug delivery systems for inhalational therapy. Expert Opinion on Drug Delivery 20:3, pages 335-348.
Read now
Antoine Guillon, Jeoffrey Pardessus, Pierre Lhommet, Christelle Parent, Renaud Respaud, Denis Marchand, Jérôme Montharu, Michèle De Monte, Philip Janiak, Christophe Boixel, Héloïse Audat, Sylvain Huille, Etienne Guillot & Nathalie Heuze-Vourc’h. (2019) Exploring the fate of inhaled monoclonal antibody in the lung parenchyma by microdialysis. mAbs 11:2, pages 297-304.
Read now
Elsa Bodier-Montagutelli, Renaud Respaud, Hervé Watier & Audrey Guillon-Munos. (2017) MAbDelivery: Administration routes for antibody therapy Third LabEx MAbImprove industrial workshop, July 2, 2015 Tours, France. mAbs 9:4, pages 579-585.
Read now
Valentino Le Noci, Michele Sommariva, Monica Tortoreto, Nadia Zaffaroni, Manuela Campiglio, Elda Tagliabue, Andrea Balsari & Lucia Sfondrini. (2016) Reprogramming the lung microenvironment by inhaled immunotherapy fosters immune destruction of tumor. OncoImmunology 5:11.
Read now
Guillaume Desoubeaux, Janice M. Reichert, Matthew Sleeman, Karen L. Reckamp, Bernhard Ryffel, Jörg P. Adamczewski, Theresa D. Sweeney, Rita Vanbever, Patrice Diot, Caroline A. Owen, Clive Page, Stéphanie Lerondel, Alain Le Pape & Nathalie Heuze-Vourc'h. (2016) Therapeutic monoclonal antibodies for respiratory diseases: Current challenges and perspectives, March 31 – April 1, 2016, Tours, France. mAbs 8:6, pages 999-1009.
Read now
Renaud Respaud, Laurent Vecellio, Patrice Diot & Nathalie Heuzé-Vourc’h. (2015) Nebulization as a delivery method for mAbs in respiratory diseases. Expert Opinion on Drug Delivery 12:6, pages 1027-1039.
Read now

Articles from other publishers (21)

Chengqian Zhang, Davide D'Angelo, Francesca Buttini & Mingshi Yang. (2023) Long-acting inhaled medicines: Present and future. Advanced Drug Delivery Reviews, pages 115146.
Crossref
Emma R. Sudduth, Michael Trautmann-Rodriguez, Nicole Gill, Kartik Bomb & Catherine A. Fromen. (2023) Aerosol pulmonary immune engineering. Advanced Drug Delivery Reviews 199, pages 114831.
Crossref
Hilal Ahmad Parray, Shivangi Shukla, Reshma Perween, Ritika Khatri, Tripti Shrivastava, Vanshika Singh, Praveenkumar Murugavelu, Shubbir Ahmed, Sweety Samal, Chandresh Sharma, Subrata Sinha, Kalpana Luthra & Rajesh Kumar. (2021) Inhalation monoclonal antibody therapy: a new way to treat and manage respiratory infections. Applied Microbiology and Biotechnology 105:16-17, pages 6315-6332.
Crossref
Bret BernerTomoyuki Okuda & Hak‐Kim Chan. 2021. Drug Delivery Approaches. Drug Delivery Approaches 305 332 .
Maxime Fieux, Sandra Le Quellec, Sophie Bartier, André Coste, Bruno Louis, Caroline Giroudon, Mikail Nourredine & Emilie Bequignon. (2021) FcRn as a Transporter for Nasal Delivery of Biologics: A Systematic Review. International Journal of Molecular Sciences 22:12, pages 6475.
Crossref
Yajie Zhang, Daniel A. Davis, Khaled AboulFotouh, Jieliang Wang, Donna Williams, Akhilesh Bhambhani, Michael Zakrewsky, Mohammed Maniruzzaman, Zhengrong Cui & Robert O. WilliamsIIIIII. (2021) Novel formulations and drug delivery systems to administer biological solids. Advanced Drug Delivery Reviews 172, pages 183-210.
Crossref
Qiutong Jin, Wenjun Zhu, Jiafei Zhu, Junjie Zhu, Jingjing Shen, Zhuang Liu, Yang Yang & Qian Chen. (2021) Nanoparticle‐Mediated Delivery of Inhaled Immunotherapeutics for Treating Lung Metastasis. Advanced Materials 33:7.
Crossref
Abigail A. Matthews, Pui Lai Rachel Ee & Ruowen Ge. (2020) Developing inhaled protein therapeutics for lung diseases. Molecular Biomedicine 1:1.
Crossref
Adam Vigil, Natalia Frias-Staheli, Teresa Carabeo & Michael Wittekind. (2020) Airway Delivery of Anti-influenza Monoclonal Antibodies Results in Enhanced Antiviral Activities and Enables Broad-Coverage Combination Therapies. Journal of Virology 94:22.
Crossref
Tomoyuki Okuda & Hirokazu Okamoto. (2020) Present Situation and Future Progress of Inhaled Lung Cancer Therapy: Necessity of Inhaled Formulations with Drug Delivery Functions. Chemical and Pharmaceutical Bulletin 68:7, pages 589-602.
Crossref
Orlagh M. Feeney, Gracia Gracia, Daniel H.S. Brundel, Natalie L. Trevaskis, Enyuan Cao, Lisa M. Kaminskas & Christopher J.H. Porter. (2020) Lymph-directed immunotherapy – Harnessing endogenous lymphatic distribution pathways for enhanced therapeutic outcomes in cancer. Advanced Drug Delivery Reviews 160, pages 115-135.
Crossref
Mohamed A. Megahed, Hossam S. El-Sawy & Khalid M. El-Say. 2020. Advances and Avenues in the Development of Novel Carriers for Bioactives and Biological Agents. Advances and Avenues in the Development of Novel Carriers for Bioactives and Biological Agents 69 103 .
Cédric Vonarburg, Marius Loetscher, Martin O. Spycher, Alain Kropf, Marlies Illi, Sharon Salmon, Sean Roberts, Karin Steinfuehrer, Ian Campbell, Sandra Koernig, Joseph Bain, Monika Edler, Ulrich Baumann, Sylvia Miescher, Dennis W. Metzger, Alexander Schaub, Fabian Käsermann & Adrian W. Zuercher. (2019) Topical application of nebulized human IgG, IgA and IgAM in the lungs of rats and non-human primates. Respiratory Research 20:1.
Crossref
Antoine Guillon, François Darrouzain, Nathalie Heuzé-Vourc’h, Antoine Petitcollin, Céline Barc, Laurent Vecellio, Bénédicte Cormier, Philippe Lanotte, Pierre Sarradin, Pierre-François Dequin, Gilles Paintaud & Stephan Ehrmann. (2019) Intra-tracheal amikacin spray delivery in healthy mechanically ventilated piglets. Pulmonary Pharmacology & Therapeutics 57, pages 101807.
Crossref
Thomas Sécher, Emilie Dalonneau, Marion Ferreira, Christelle Parent, Nicolas Azzopardi, Gilles Paintaud, Mustapha Si-Tahar & Nathalie Heuzé-Vourc'h. (2019) In a murine model of acute lung infection, airway administration of a therapeutic antibody confers greater protection than parenteral administration. Journal of Controlled Release 303, pages 24-33.
Crossref
T. Sécher, L. Guilleminault, K. Reckamp, I. Amanam, L. Plantier & N. Heuzé-Vourc'h. (2018) Therapeutic antibodies: A new era in the treatment of respiratory diseases?. Pharmacology & Therapeutics 189, pages 149-172.
Crossref
Paul J. Carter & Greg A. Lazar. (2017) Next generation antibody drugs: pursuit of the 'high-hanging fruit'. Nature Reviews Drug Discovery 17:3, pages 197-223.
Crossref
A. Guillon, T. Sécher, L.A. Dailey, L. Vecellio, M. de Monte, M. Si-Tahar, P. Diot, C.P. Page & N. Heuzé-Vourc’h. (2018) Insights on animal models to investigate inhalation therapy: Relevance for biotherapeutics. International Journal of Pharmaceutics 536:1, pages 116-126.
Crossref
Gino Van Heeke, Koen Allosery, Veronique De Brabandere, Tim De Smedt, Laurent Detalle & Antonin de Fougerolles. (2017) Nanobodies® † †Nanobody is a registered trademark of Ablynx NV. as inhaled biotherapeutics for lung diseases. Pharmacology & Therapeutics 169, pages 47-56.
Crossref
Renaud Respaud, Denis Marchand, Thibaut Pelat, Kam-Meng Tchou-Wong, Chad J. Roy, Christelle Parent, Maria Cabrera, Joël Guillemain, Ronan Mac Loughlin, Eric Levacher, Alexandre Fontayne, Laurence Douziech-Eyrolles, Alexandra Junqua-Moullet, Laurent Guilleminault, Philippe Thullier, Emmanuelle Guillot-Combe, Laurent Vecellio & Nathalie Heuzé-Vourc'h. (2016) Development of a drug delivery system for efficient alveolar delivery of a neutralizing monoclonal antibody to treat pulmonary intoxication to ricin. Journal of Controlled Release 234, pages 21-32.
Crossref
Martin P Barr, Kenneth J O'Byrne, Nael Al-Sarraf & Steven G Gray. (2015) VEGF-mediated cell survival in non-small-cell lung cancer: implications for epigenetic targeting of VEGF receptors as a therapeutic approach. Epigenomics 7:6, pages 897-910.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.